HK Stock Market Move | STAR SPORTS MED (01609) surges over 26% again; all products obtain CE MDR certification; the company was previously officially included as a Hong Kong Stock Connect target.

STAR SPORTS MED (01609) surged over 26% again, rising 17.92% as of press time to HK$125, with a turnover of HK$172 million. On the news front, STAR SPORTS MED announced that it recently received the EU Medical Device Regulation (CE MDR) certification, making it the first sports medicine manufacturer in China to obtain CE MDR certification for its entire product line. Meanwhile, the company has received product registration approvals in multiple overseas markets. The announcement stated that obtaining the certification and registration certificates marks that more of the company's products comply with the regulatory requirements of the EU and the aforementioned countries, which is conducive to the company further expanding its overseas business layout in the EU, Latin America, and Southeast Asia, and further enhancing the company's competitiveness and product layout in the international market. Previously, STAR SPORTS MED was officially included as a Hong Kong Stock Connect target and selected for inclusion in the Hang Seng Composite Index. It is reported that STAR SPORTS MED is a leading comprehensive sports medicine solutions provider in China, focusing on the R&D, production, and commercialization of sports medicine implants, surgical equipment, and related consumables. According to China Insights Consultancy data, based on 2024 sales revenue, STAR SPORTS MED is China's fourth-largest and the largest domestic supplier of sports medicine implants and devices, with a market share of 6.5%.